The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pre-Clinical Imaging (In-VIVO) Systems Market Research Report 2024

Global Pre-Clinical Imaging (In-VIVO) Systems Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1892137

No of Pages : 88

Synopsis
Pre-clinical (in-vivo) imaging is bridging a gap between the vivo clinical research and vitro exploratory. It is increasingly being deployed across the drug development process, specifically in oncology therapeutic area. The advanced research and development facilities and new product developments of the companies are supporting the growth of pre-clinical imaging (in-vivo) industry. Moreover, integration of pre-clinical MRI systems with other imaging modalities is also expected to propel the growth of the global pre-clinical imaging market in coming years.
The global Pre-Clinical Imaging (In-VIVO) Systems market was valued at US$ 824.3 million in 2023 and is anticipated to reach US$ 1105.1 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
North American market for Pre-Clinical Imaging (In-VIVO) Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pre-Clinical Imaging (In-VIVO) Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pre-Clinical Imaging (In-VIVO) Systems include Perkinelmer, Mr Solutions, Mediso, Bruker Corporation, Trifoil Imaging, Fujifilm Visualsonics, Biospace Lab, Milabs and Li-Cor Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pre-Clinical Imaging (In-VIVO) Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Clinical Imaging (In-VIVO) Systems.
Report Scope
The Pre-Clinical Imaging (In-VIVO) Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pre-Clinical Imaging (In-VIVO) Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pre-Clinical Imaging (In-VIVO) Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkinelmer
Mr Solutions
Mediso
Bruker Corporation
Trifoil Imaging
Fujifilm Visualsonics
Biospace Lab
Milabs
Li-Cor Biosciences
Thermo Fisher Scientific
Agilent Technologies
Aspect Imaging
Segment by Type
Optical Imaging Systems
Nuclear Imaging Systems
Micro-Magnetic Resonance Imaging (MRI)
Micro-Ultrasound
Photoacoustic Imaging System
Magnetic Particle Imaging System
Others
Segment by Application
Clinic
Hospital
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pre-Clinical Imaging (In-VIVO) Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pre-Clinical Imaging (In-VIVO) Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Pre-Clinical Imaging (In-VIVO) Systems Market Overview
1.1 Product Overview and Scope of Pre-Clinical Imaging (In-VIVO) Systems
1.2 Pre-Clinical Imaging (In-VIVO) Systems Segment by Type
1.2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Market Value Comparison by Type (2024-2030)
1.2.2 Optical Imaging Systems
1.2.3 Nuclear Imaging Systems
1.2.4 Micro-Magnetic Resonance Imaging (MRI)
1.2.5 Micro-Ultrasound
1.2.6 Photoacoustic Imaging System
1.2.7 Magnetic Particle Imaging System
1.2.8 Others
1.3 Pre-Clinical Imaging (In-VIVO) Systems Segment by Application
1.3.1 Global Pre-Clinical Imaging (In-VIVO) Systems Market Value by Application: (2024-2030)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Pre-Clinical Imaging (In-VIVO) Systems Market Size Estimates and Forecasts
1.4.1 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue 2019-2030
1.4.2 Global Pre-Clinical Imaging (In-VIVO) Systems Sales 2019-2030
1.4.3 Global Pre-Clinical Imaging (In-VIVO) Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pre-Clinical Imaging (In-VIVO) Systems Market Competition by Manufacturers
2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pre-Clinical Imaging (In-VIVO) Systems Average Price by Manufacturers (2019-2024)
2.4 Global Pre-Clinical Imaging (In-VIVO) Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pre-Clinical Imaging (In-VIVO) Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pre-Clinical Imaging (In-VIVO) Systems, Product Type & Application
2.7 Pre-Clinical Imaging (In-VIVO) Systems Market Competitive Situation and Trends
2.7.1 Pre-Clinical Imaging (In-VIVO) Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pre-Clinical Imaging (In-VIVO) Systems Players Market Share by Revenue
2.7.3 Global Pre-Clinical Imaging (In-VIVO) Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pre-Clinical Imaging (In-VIVO) Systems Retrospective Market Scenario by Region
3.1 Global Pre-Clinical Imaging (In-VIVO) Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pre-Clinical Imaging (In-VIVO) Systems Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Region: 2019-2030
3.2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Region: 2019-2024
3.2.2 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Region: 2025-2030
3.3 Global Pre-Clinical Imaging (In-VIVO) Systems Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Region: 2019-2030
3.3.1 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Region: 2019-2024
3.3.2 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Region: 2025-2030
3.4 North America Pre-Clinical Imaging (In-VIVO) Systems Market Facts & Figures by Country
3.4.1 North America Pre-Clinical Imaging (In-VIVO) Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pre-Clinical Imaging (In-VIVO) Systems Sales by Country (2019-2030)
3.4.3 North America Pre-Clinical Imaging (In-VIVO) Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pre-Clinical Imaging (In-VIVO) Systems Market Facts & Figures by Country
3.5.1 Europe Pre-Clinical Imaging (In-VIVO) Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pre-Clinical Imaging (In-VIVO) Systems Sales by Country (2019-2030)
3.5.3 Europe Pre-Clinical Imaging (In-VIVO) Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pre-Clinical Imaging (In-VIVO) Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Pre-Clinical Imaging (In-VIVO) Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pre-Clinical Imaging (In-VIVO) Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Pre-Clinical Imaging (In-VIVO) Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pre-Clinical Imaging (In-VIVO) Systems Market Facts & Figures by Country
3.7.1 Latin America Pre-Clinical Imaging (In-VIVO) Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pre-Clinical Imaging (In-VIVO) Systems Sales by Country (2019-2030)
3.7.3 Latin America Pre-Clinical Imaging (In-VIVO) Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pre-Clinical Imaging (In-VIVO) Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Pre-Clinical Imaging (In-VIVO) Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pre-Clinical Imaging (In-VIVO) Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pre-Clinical Imaging (In-VIVO) Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Type (2019-2030)
4.1.1 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Type (2019-2024)
4.1.2 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Type (2025-2030)
4.1.3 Global Pre-Clinical Imaging (In-VIVO) Systems Sales Market Share by Type (2019-2030)
4.2 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Type (2019-2030)
4.2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Type (2019-2024)
4.2.2 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Type (2025-2030)
4.2.3 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue Market Share by Type (2019-2030)
4.3 Global Pre-Clinical Imaging (In-VIVO) Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Application (2019-2030)
5.1.1 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Application (2019-2024)
5.1.2 Global Pre-Clinical Imaging (In-VIVO) Systems Sales by Application (2025-2030)
5.1.3 Global Pre-Clinical Imaging (In-VIVO) Systems Sales Market Share by Application (2019-2030)
5.2 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Application (2019-2030)
5.2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Application (2019-2024)
5.2.2 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue by Application (2025-2030)
5.2.3 Global Pre-Clinical Imaging (In-VIVO) Systems Revenue Market Share by Application (2019-2030)
5.3 Global Pre-Clinical Imaging (In-VIVO) Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Perkinelmer
6.1.1 Perkinelmer Corporation Information
6.1.2 Perkinelmer Description and Business Overview
6.1.3 Perkinelmer Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Perkinelmer Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.1.5 Perkinelmer Recent Developments/Updates
6.2 Mr Solutions
6.2.1 Mr Solutions Corporation Information
6.2.2 Mr Solutions Description and Business Overview
6.2.3 Mr Solutions Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mr Solutions Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.2.5 Mr Solutions Recent Developments/Updates
6.3 Mediso
6.3.1 Mediso Corporation Information
6.3.2 Mediso Description and Business Overview
6.3.3 Mediso Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mediso Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.3.5 Mediso Recent Developments/Updates
6.4 Bruker Corporation
6.4.1 Bruker Corporation Corporation Information
6.4.2 Bruker Corporation Description and Business Overview
6.4.3 Bruker Corporation Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bruker Corporation Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.4.5 Bruker Corporation Recent Developments/Updates
6.5 Trifoil Imaging
6.5.1 Trifoil Imaging Corporation Information
6.5.2 Trifoil Imaging Description and Business Overview
6.5.3 Trifoil Imaging Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Trifoil Imaging Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.5.5 Trifoil Imaging Recent Developments/Updates
6.6 Fujifilm Visualsonics
6.6.1 Fujifilm Visualsonics Corporation Information
6.6.2 Fujifilm Visualsonics Description and Business Overview
6.6.3 Fujifilm Visualsonics Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fujifilm Visualsonics Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.6.5 Fujifilm Visualsonics Recent Developments/Updates
6.7 Biospace Lab
6.6.1 Biospace Lab Corporation Information
6.6.2 Biospace Lab Description and Business Overview
6.6.3 Biospace Lab Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biospace Lab Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.7.5 Biospace Lab Recent Developments/Updates
6.8 Milabs
6.8.1 Milabs Corporation Information
6.8.2 Milabs Description and Business Overview
6.8.3 Milabs Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Milabs Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.8.5 Milabs Recent Developments/Updates
6.9 Li-Cor Biosciences
6.9.1 Li-Cor Biosciences Corporation Information
6.9.2 Li-Cor Biosciences Description and Business Overview
6.9.3 Li-Cor Biosciences Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Li-Cor Biosciences Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.9.5 Li-Cor Biosciences Recent Developments/Updates
6.10 Thermo Fisher Scientific
6.10.1 Thermo Fisher Scientific Corporation Information
6.10.2 Thermo Fisher Scientific Description and Business Overview
6.10.3 Thermo Fisher Scientific Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Thermo Fisher Scientific Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.10.5 Thermo Fisher Scientific Recent Developments/Updates
6.11 Agilent Technologies
6.11.1 Agilent Technologies Corporation Information
6.11.2 Agilent Technologies Pre-Clinical Imaging (In-VIVO) Systems Description and Business Overview
6.11.3 Agilent Technologies Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Agilent Technologies Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.11.5 Agilent Technologies Recent Developments/Updates
6.12 Aspect Imaging
6.12.1 Aspect Imaging Corporation Information
6.12.2 Aspect Imaging Pre-Clinical Imaging (In-VIVO) Systems Description and Business Overview
6.12.3 Aspect Imaging Pre-Clinical Imaging (In-VIVO) Systems Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aspect Imaging Pre-Clinical Imaging (In-VIVO) Systems Product Portfolio
6.12.5 Aspect Imaging Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pre-Clinical Imaging (In-VIVO) Systems Industry Chain Analysis
7.2 Pre-Clinical Imaging (In-VIVO) Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pre-Clinical Imaging (In-VIVO) Systems Production Mode & Process
7.4 Pre-Clinical Imaging (In-VIVO) Systems Sales and Marketing
7.4.1 Pre-Clinical Imaging (In-VIVO) Systems Sales Channels
7.4.2 Pre-Clinical Imaging (In-VIVO) Systems Distributors
7.5 Pre-Clinical Imaging (In-VIVO) Systems Customers
8 Pre-Clinical Imaging (In-VIVO) Systems Market Dynamics
8.1 Pre-Clinical Imaging (In-VIVO) Systems Industry Trends
8.2 Pre-Clinical Imaging (In-VIVO) Systems Market Drivers
8.3 Pre-Clinical Imaging (In-VIVO) Systems Market Challenges
8.4 Pre-Clinical Imaging (In-VIVO) Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’